Skip to Content
NIH - National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Center for Cancer Research
NCI Experimental Therapeutics Program (NExT)
Contact NExT
Show menu
Search this site
Last Updated: 10/22/18

Inaugural Chemical Biology Consortium Symposium:
Bridging the Gaps of Drug Discovery

University of California, San Francisco
Mission Bay Conference Center, Rutter Center, Fisher Banquet Room, 1675 Owens Street, San Francisco, CA 94143
November 16th, 2018

Time Title
8:00am Registration & Coffee
8:30am Welcome and Introduction to CBC and UCSF; Barbara Mroczkowski, PhD, Michelle Arkin, PhD, Pamela Munster, MD, Charles Craik, PhD
8:45am Discovery and Characterization of Picomolar Inhibitors of WDR5; Taekyu Lee, PhD (Vanderbilt), William Tansey PhD (Vanderbilt)
9:30am Scaffold-based Discovery of Anti-Tumor Compounds; Gideon Bollag, PhD (Plexxikon)
10:00am Fingerprints for Immuno-Oncology Response; Adil Daud, MD (UCSF)
10:30am Coffee Break
11:00am Histone Deacetylase Inhibitors in the Clinic; Pamela Munster, MD (UCSF)
11:30am Attacking the Cell Surfaceome in Cancer, Jim Wells, PhD (UCSF)
12:00pm Lunch
1:00pm Atypical Protein Kinases — From Mechanisms to Therapy; Natalia Jura, PhD (UCSF)
1:30pm Oncology Diagnostic Development in the Era of Genomics and Immunooncology; Mark Lackner, PhD, (IDEAYA Biosciences)
2:00pm STAT3 Decoys; Jennifer Grandis, MD (UCSF)
2:30pm Coffee Break
3:00pm Inducing Androgen Receptor Degradation By Targeting Molecular Chaperones; Jason Gestwicki, PhD (UCSF)
3:30pm Co-opting the Ubiquitin System for Therapeutic Benefit; Ingrid Wertz, PhD (Genentech)
4:00pm Poster Flash Talks
5:00pm Poster Session
6:30pm Meeting Adjourned